Thrice-weekly low dose rituximab decreases CD20 loss via shaving and suggests enhanced therapeutic targeting in chronic lymphocytic leukemia (CLL)R Taylor,M Williams, A Pawluczkowycz, P Beum,A Kennedy,M Lindorfer, D Barnd, G Patroni, J Eggleton, S Hamil,J DensmoreANNALS OF ONCOLOGY（2005）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
